Skip to main content

Table 1 Clinical characteristics, medical treatment and coronary revascularization procedures at enrollment in the entire population stratified by the first clinical presentation of IHD (Angina vs unheralded Myocardial infarction)

From: Long-term prognosis of unheralded myocardial infarction vs chronic angina; role of sex and coronary atherosclerosis burden

  Total 2772 Angina (1353) Myocardial Infarction (1419) p-value
Sex males, N(%) 2250 (81) 1033 (76) 1217 (86) 0.001
Age at disease onset (yrs) 55 ± 9 56 ± 9 54 ± 9 < 0.001
Age at hospitalization (yrs) 59 ± 8 60 ± 7 58 ± 8 < 0.001
IHD Family history, N(%) 1411 (51) 716 (53) 695 (49) 0.038
Smoking, N(%) 1588 (57) 656 (49) 932 (66) < 0.001
Obesity, N(%) 795 (29) 400 (30) 395 (28) 315
BMI, mean ± SD 27.5 28 ± 4 27 ± 4 0.363
Diabetes, N(%) 576 (21) 273 (20) 303 (21) 0.446
Hypertension, N(%) 1439 (52) 779 (58) 660 (47) 0.001
Hypercholesterolemia, N(%) 1923 (69) 954 (71) 969 (68) 0.204
Hypertriglyceridemia, N(%) 735 (27) 365 (27) 370 (26) 0.591
Glycaemia, mean ± SD 111 ± 49 107 ± 38 115 ± 57 < 0.001
Systolic Blood Pressure 133 ± 21 136 ± 20 130 ± 22 < 0.001
Diastolic Blood Pressure 76 ± 11 76 ± 11 75 ± 12 < 0.001
Total Cholesterol mean ± SD 198 ± 46 204 ± 45 193 ± 47 < 0.001
HDL 41 ± 15 43 ± 15 39 ± 16 < 0.001
LDL 123 ± 45 129 ± 49 118 ± 40 < 0.001
Triglycerides 146 ± 97 147 ± 96 146 ± 98 0.825
Previous CABG, N(%) 194 (7) 61 (5) 133 (9) < 0.001
Previous PCI, N(%) 382 (14) 146 (11) 236 (17) < 0.001
Coronary Atherosclerosis 1.47 ± 1.03 1.31 ± 1.05 1.64 ± 0.94 < 0.001
EF% 53 ± 10 57 ± 7 49 ± 11 < 0.001
Medications (%)
Anti-platelet agents 2371 (86) 1108 (82) 1263 (89) < 0.001
Calcium channel blockers 832 (30) 502 (37) 330 (23) < 0.001
Nitrates 1792 (65) 830 (61) 962 (68) < 0.001
ACE Inhibitors 943 (34) 332 (25) 611 (43) < 0.001
Betablockers 1320 (48) 543 (40) 777 (55) < 0.001
Statins 1514 (55) 706 (52) 808 (57) 0.011
Antidiabetics 429 (16) 202 (15) 227 (16) 0.437
  1. IHD Ischemic Heart Disease, BMI Body Mass Index, PCI Percutaneous Coronary Intervention, CABG Coronary Artery Bypass Graft, Coronary Atherosclerosis (number of main coronary vessels, with > 50% lumen reduction, mean ± SD); EF Ejection Fraction